These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17711922)

  • 1. Secretin-receptor and secretin-receptor-variant expression in gastrinomas: correlation with clinical and tumoral features and secretin and calcium provocative test results.
    Long SH; Berna MJ; Thill M; Pace A; Pradhan TK; Hoffmann KM; Serrano J; Jensen RT
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4394-402. PubMed ID: 17711922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominant negative action of an abnormal secretin receptor arising from mRNA missplicing in a gastrinoma.
    Ding WQ; Kuntz S; Böhmig M; Wiedenmann B; Miller LJ
    Gastroenterology; 2002 Feb; 122(2):500-11. PubMed ID: 11832464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the calcium-sensing receptor in gastrinomas.
    Goebel SU; Peghini PL; Goldsmith PK; Spiegel AM; Gibril F; Raffeld M; Jensen RT; Serrano J
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4131-7. PubMed ID: 11095444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum gastrin in Zollinger-Ellison syndrome: II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature. evaluation of diagnostic criteria, proposal of new criteria, and correlations with clinical and tumoral features.
    Berna MJ; Hoffmann KM; Long SH; Serrano J; Gibril F; Jensen RT
    Medicine (Baltimore); 2006 Nov; 85(6):331-364. PubMed ID: 17108779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype/phenotype correlation of multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas.
    Goebel SU; Heppner C; Burns AL; Marx SJ; Spiegel AM; Zhuang Z; Lubensky IA; Gibril F; Jensen RT; Serrano J
    J Clin Endocrinol Metab; 2000 Jan; 85(1):116-23. PubMed ID: 10634374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment and prediction of long-term cure in patients with the Zollinger-Ellison syndrome: the best approach.
    Fishbeyn VA; Norton JA; Benya RV; Pisegna JR; Venzon DJ; Metz DC; Jensen RT
    Ann Intern Med; 1993 Aug; 119(3):199-206. PubMed ID: 8323088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of insulin-like growth factor I and/or its receptor in gastrinomas is associated with low curability, increased growth, and development of metastases.
    Furukawa M; Raffeld M; Mateo C; Sakamoto A; Moody TW; Ito T; Venzon DJ; Serrano J; Jensen RT
    Clin Cancer Res; 2005 May; 11(9):3233-42. PubMed ID: 15867218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of gastrinomas by immunohistochemistry and in situ hybridization histochemistry.
    Perkins PL; McLeod MK; Jin L; Fukuuchi A; Cho KJ; Thompson NW; Lloyd RV
    Diagn Mol Pathol; 1992 Sep; 1(3):155-64. PubMed ID: 1285276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features.
    Anlauf M; Garbrecht N; Henopp T; Schmitt A; Schlenger R; Raffel A; Krausch M; Gimm O; Eisenberger CF; Knoefel WT; Dralle H; Komminoth P; Heitz PU; Perren A; Klöppel G
    World J Gastroenterol; 2006 Sep; 12(34):5440-6. PubMed ID: 17006979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of secretin receptor function by dimerization with a misspliced variant secretin receptor in ductal pancreatic adenocarcinoma.
    Ding WQ; Cheng ZJ; McElhiney J; Kuntz SM; Miller LJ
    Cancer Res; 2002 Sep; 62(18):5223-9. PubMed ID: 12234988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of epidermal growth factor and hepatocyte growth factor receptors in a proportion of gastrinomas correlates with aggressive growth and lower curability.
    Peghini PL; Iwamoto M; Raffeld M; Chen YJ; Goebel SU; Serrano J; Jensen RT
    Clin Cancer Res; 2002 Jul; 8(7):2273-85. PubMed ID: 12114431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome.
    Frucht H; Howard JM; Stark HA; McCarthy DM; Maton PN; Gardner JD; Jensen RT
    Am J Med; 1989 Nov; 87(5):528-36. PubMed ID: 2573280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome.
    Alexander HR; Fraker DL; Norton JA; Bartlett DL; Tio L; Benjamin SB; Doppman JL; Goebel SU; Serrano J; Gibril F; Jensen RT
    Ann Surg; 1998 Aug; 228(2):228-38. PubMed ID: 9712569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Zollinger-Ellison syndrome].
    Fendrich V; Bartsch DK; Langer P; Zielke A; Rothmund M
    Chirurg; 2005 Mar; 76(3):217-26. PubMed ID: 15688179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing treatment strategy for gastrinoma in patients with Zollinger-Ellison syndrome.
    Imamura M; Komoto I; Ota S
    World J Surg; 2006 Jan; 30(1):1-11. PubMed ID: 16369713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous calcium injection test is a novel complementary procedure in differential diagnosis for gastrinoma.
    Wada M; Komoto I; Doi R; Imamura M
    World J Surg; 2002 Oct; 26(10):1291-6. PubMed ID: 12205549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretin Stimulation Test and Early Diagnosis of Gastrinoma in MEN1 Syndrome: Survey on the MEN1 Florentine Database.
    Giusti F; Cioppi F; Fossi C; Marini F; Masi L; Tonelli F; Brandi ML
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e2110-e2123. PubMed ID: 34922358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretin and calcium provocative tests in the Zollinger-Ellison syndrome. A prospective study.
    Frucht H; Howard JM; Slaff JI; Wank SA; McCarthy DM; Maton PN; Vinayek R; Gardner JD; Jensen RT
    Ann Intern Med; 1989 Nov; 111(9):713-22. PubMed ID: 2572194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of secretin to stimulate gastrin release and adenylate cyclase activity in gastrinoma in vitro.
    Ellison EC; O'Dorisio MS; O'Dorisio T; Sparks J; Vasallo L; Woltering EA
    Surgery; 1984 Dec; 96(6):1019-26. PubMed ID: 6095476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretin receptors in normal and diseased human pancreas: marked reduction of receptor binding in ductal neoplasia.
    Körner M; Hayes GM; Rehmann R; Zimmermann A; Friess H; Miller LJ; Reubi JC
    Am J Pathol; 2005 Oct; 167(4):959-68. PubMed ID: 16192632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.